A review of the psychopharmacology of panic disorder: individual differences and non specific factors.
This paper critically examines the pharmacological provocation and treatment of panic disorder. An analysis of research findings on how panic attacks are induced indicates that there are psychological and non specific factors that may mediate biochemical etiological models, and these individual differences need to be investigated further. This has important implications for the psychopharmacological management of panic. A review of studies on treating panic disorder with imipramine and alprazolam emphasizes the importance of several non specific factors that include the role of self-directed in vivo exposure and changes in dysphoria and self-efficacy (subjective beliefs regarding personal competency) in predicting outcome. It is recommended that any treatment of panic-related disorders include self-directed, in vivo exposure.
Cox
B J
BJ
Department of Psychology, York University, Toronto, Ontario.
Swinson
R P
RP
Endler
N S
NS
D000379:Agoraphobia / Q000188:drug therapy / Q000523:psychology; D000525:Alprazolam / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D003131:Combined Modality Therapy; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D010200:Panic / Q000187:drug effects*; D010624:Phenelzine / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use*
D011619:Psychotropic Drugs; D010624:Phenelzine; D007099:Imipramine; D000525:Alprazolam